US 12042529
Optimization of enzyme replacement therapy for treatment of homocystinuria
granted A61KA61K38/51A61K47/60
Quick answer
US patent 12042529 (Optimization of enzyme replacement therapy for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/51, A61K47/60